Esperion Therapeutics Inc. (ESPR)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
11 May 2023 |
CARROLL J MARTIN |
Director |
11 May 2023 |
23,091 |
1.57 |
36,285 |
11 May 2023 |
CARROLL J MARTIN |
Director |
10 May 2023 |
8,409 |
1.49 |
12,545 |
11 May 2023 |
ROCAMBOLI STEPHEN |
Director |
10 May 2023 |
8,111 |
1.50 |
12,126 |
10 May 2023 |
KOENIG SHELDON L. |
President and CEO |
09 May 2023 |
20,000 |
1.26 |
25,192 |
31 Aug 2022 |
WARREN ERIC |
Chief Commercial Officer |
31 Aug 2022 |
1,000 |
7.46 |
7,460 |
08 Aug 2022 |
KOENIG SHELDON L. |
President and CEO |
05 Aug 2022 |
8,606 |
5.80 |
49,950 |
03 Jun 2022 |
CARROLL J MARTIN |
Director |
02 Jun 2022 |
5,000 |
5.64 |
28,180 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock